EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Best Treatment Options for Severe Helicobacter pylori Infections

Gulhan Kanat Unler, Ozgur Hilal Erinanc, Aydın Karakoca, Huseyin Savas Gokturk

Turkish Journal of Gastroenterology · 2025

DOI: 10.5152/tjg.2025.24543 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Gastroenterology, 2025. Verfasst von Gulhan Kanat Unler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Başkent University Faculty of Medicine, Konya, Türkiye. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori, Clarithromycin, Anti-Bacterial Agents. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims :Helicobacter pylori (H. pylori) affects half of the world’s population. Increasing antibiotic resistance seems to be causing significant clinical problems. The efficacy of bismuth-containing sequential therapy with clarithromycin (BSTC), bismuth-containing sequential therapy with levofloxacin (BSTL), and bismuth-containing quadruple therapy (BQT) regimens on H. pylori eradication was investigated. The authors also investigated whether high gastric H. pylori colonization density affected treatment success through different treatment regimens. Materials and Methods: A total of 751 H. pylori–positive patients were included retrospectively in the following treatment groups: sequential therapy with clarithromycin, sequential therapy with levofloxacin, and bismuth-containing quadruple therapy.

Results

There was a significant difference between the 3 treatment protocols in terms of treatment success rates. When the success rates of the applied treatments were examined, the highest success rate was BSTL (85.3%), which was statistically significantly higher than BQT (74.8%) and BSTC (74.8%). A significant difference was found between the success rates of the protocols applied in the group with high bacterial density (P = .003). The success rates in this group were calculated as BSTL (88.6%), BQT (71.4%), and BSTC (79.4%).

Conclusion

It was concluded that BSTL may be the best option for treating H. pylori infections in first-line treatment. This regimen is particularly effective in cases of severe H. pylori colonization. Cite this article as: Unler GK, Hilal Erinanc O, Karakoca A, Savas Gokturk H. Best treatment options for severe helicobacter pylori infections. Turk J Gastroenterol. 2025;36(12):807-812.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriClarithromycinAnti-Bacterial AgentsBismuthHumansRetrospective StudiesFemaleMaleDrug Therapy, CombinationLevofloxacinMiddle AgedTreatment OutcomeAdultAgedSeverity of Illness Index

Stichwörter der Autor:innen

H. pylorieradication regimenssevere colonization

Substanzen

ClarithromycinAnti-Bacterial AgentsLevofloxacinBismuth

Autor:innen und Institutionen

  • Department of Gastroenterology, Başkent University Faculty of Medicine, Konya, Türkiye.
  • Department of Pathology, Baskent University Faculty of Medicine, Konya, Türkiye.
  • Department of Statistics, Necmettin Erbakan University Faculty of Science, Konya, Türkiye.

Zitieren

APA

Kanat Unler, G., Erinanc, O. H., Karakoca, A., & Gokturk, H. S. (2025). Best Treatment Options for Severe Helicobacter pylori Infections. Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2025.24543

Vancouver

Kanat Unler G, Erinanc OH, Karakoca A, Gokturk HS. Best Treatment Options for Severe Helicobacter pylori Infections. Turkish Journal of Gastroenterology. 2025. doi:10.5152/tjg.2025.24543

BibTeX
@article{KanatUnler2025,
  author = {Kanat Unler, Gulhan and Erinanc, Ozgur Hilal and Karakoca, Aydın and Gokturk, Huseyin Savas},
  title = {Best Treatment Options for Severe Helicobacter pylori Infections},
  journal = {Turkish Journal of Gastroenterology},
  year = {2025},
  doi = {10.5152/tjg.2025.24543}
}
Kostenlos starten →